Apple Inc. Q3 2021 10-Q Summary
Business Context and Reporting Period
This filing is a Quarterly Report on Form 10-Q for Apple Inc. for the fiscal quarter ended June 26, 2021. The company operates globally, selling hardware products (iPhone, Mac, iPad, Wearables) and services. The reporting period reflects the third quarter of fiscal year 2021, a 52-week fiscal year.
Key Financial Metrics
| Metric | Q3 2021 | Q3 2020 | 9 Months 2021 | 9 Months 2020 |
|---|---|---|---|---|
| Total Net Sales | $81.4 billion | $59.7 billion | $282.5 billion | $209.8 billion |
| Net Income | $21.7 billion | $11.3 billion | $74.1 billion | $44.7 billion |
| Diluted EPS | $1.30 | $0.65 | $4.38 | $2.54 |
| Gross Margin % | 43.3% | 38.0% | 41.7% | 38.3% |
| Operating Cash Flow (9mo) | $83.8 billion (vs $60.1 billion prior year) | |||
| Total Debt (Term + CP) | $121.8 billion ($113.2B Term + $8.0B CP) | |||
| Cash & Marketable Securities | $193.6 billion |
Material Changes vs. Prior Period
- Revenue Growth: Total net sales increased 36% year-over-year in Q3 2021, driven by growth across all product and service categories.
- Product Performance: iPhone sales rose 50% to $39.6 billion; Wearables, Home, and Accessories grew 36% to $8.8 billion; Services grew 33% to $17.5 billion.
- Geographic Expansion: Greater China saw the highest growth at 58%, followed by Europe (34%) and the Americas (33%).
- Margin Expansion: Gross margin percentage improved to 43.3% from 38.0% in the prior year quarter, attributed to product mix, foreign currency strength, and improved leverage.
- Capital Return: The company repurchased $22.5 billion of common stock and paid $3.8 billion in dividends during the quarter.
Outlook, Risks, and Contingencies
- Guidance: The filing does not provide specific numerical guidance for future quarters. Management expects gross margins to remain subject to volatility and downward pressure.
- COVID-19 Impact: While retail stores and offices have largely reopened, the pandemic continues to affect operations, supply chains, and demand. The extent of future impact remains uncertain.
- Legal Contingencies:
- European Commission State Aid: Approximately €12.7 billion (plus interest) remains in escrow pending the conclusion of legal proceedings regarding Irish tax rulings.
- Patent Litigation: Ongoing disputes with VirnetX and Optis regarding patent infringement, with varying stages of appeal and retrial.
- French Competition Authority: A €1.1 billion fine regarding sales practices in France has been appealed.
- Supply Chain: The company faces risks related to component shortages and reliance on single-source suppliers for custom components.
Investor Verification Checklist
- Verify the sustainability of the 43.3% gross margin given management's warning of potential downward pressure.
- Monitor the resolution of the European Commission State Aid Decision and its potential impact on cash reserves.
- Assess the impact of ongoing global supply chain constraints on future product availability and revenue recognition.
- Review the status of the Accelerated Share Repurchase (ASR) agreement initiated in May 2021 to determine final share count and average price.
- Track the outcome of pending patent litigation (VirnetX, Optis) and the French Competition Authority appeal for potential liability exposure.